Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030

1 INTRODUCTION 47 1.1 STUDY OBJECTIVES 47 1.2 MARKET DEFINITION 47 1.3 STUDY SCOPE 47 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 48 1.3.2 YEARS CONSIDERED 49 1.3.3 INCLUSIONS AND EXCLUSIONS 49 1.4 CURRENCY CONSIDERED 50 1.5 STAKEHOLDERS 51 1.6 SUMMARY OF CHANGES 51 2 RESEARCH METHODOLOGY 52 2.1 RESEARCH DATA 52 2.1.1 SECONDARY DATA 53 2.1.2 PRIMARY DATA 53 2.2 MARKET SIZE ESTIMATION METHODOLOGY 55 2.2.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION 55 2.2.2 INSIGHTS FROM PRIMARY EXPERTS 57 2.2.3 TOP-DOWN APPROACH 58 2.3 MARKET GROWTH RATE PROJECTIONS 59 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 61 2.5 RESEARCH ASSUMPTIONS 62 2.6 RISK ANALYSIS 62 2.7 RESEARCH LIMITATIONS 62 3 EXECUTIVE SUMMARY 64 4 PREMIUM INSIGHTS 68 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET 68 4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE AND COUNTRY 69 4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 69 4.4 SINGLE-CELL ANALYSIS MARKET, BY END USER 70 4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70   5 MARKET OVERVIEW 71 5.1 INTRODUCTION 71 5.2 MARKET DYNAMICS 71 5.2.1 DRIVERS 73 5.2.1.1 Technological advancements in single-cell analysis products 73 5.2.1.2 Rising prevalence of cancer 74 5.2.1.3 Increasing R&D in pharmaceutical and biotechnology industries 75 5.2.1.4 Growth in stem cell research 76 5.2.1.5 Growing focus on personalized medicine 78 5.2.2 RESTRAINTS 79 5.2.2.1 High cost of single-cell analysis products 79 5.2.3 OPPORTUNITIES 80 5.2.3.1 High growth potential of single-cell sequencing 80 5.2.3.2 Integration of microfluidics in single-cell analysis 80 5.2.3.3 Rising potential in emerging Asian markets 81 5.2.4 CHALLENGES 81 5.2.4.1 Lack of standardization in protocols and quality control procedures 81 5.2.4.2 Technical limitations of single-cell analysis 82 5.2.4.3 Mounting ethical and privacy concerns 82 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82 5.4 VALUE CHAIN ANALYSIS 83 5.5 ECOSYSTEM ANALYSIS 85 5.6 TECHNOLOGY ANALYSIS 88 5.6.1 KEY TECHNOLOGIES 88 5.6.1.1 Flow cytometry 88 5.6.1.2 Next-generation sequencing 88 5.6.1.3 Polymerase chain reaction 89 5.6.1.4 Microscopy 89 5.6.1.5 Mass spectrometry 90 5.6.2 COMPLEMENTARY TECHNOLOGIES 90 5.6.2.1 Bioinformatics tools and computational analysis 90 5.6.2.2 Multi-omics integration 91 5.6.3 ADJACENT TECHNOLOGIES 92 5.6.3.1 Nanotechnology 92 5.6.3.2 Artificial intelligence and machine learning 92 5.7 PATENT ANALYSIS 92 5.7.1 METHODOLOGY 92 5.7.2 PATENTS APPLIED AND GRANTED, 2014–2024 92   5.8 TRADE ANALYSIS 95 5.8.1 IMPORT DATA (HS CODE 9027) 95 5.8.2 EXPORT DATA (HS CODE 9027) 97 5.9 PORTER’S FIVE FORCES ANALYSIS 99 5.9.1 THREAT OF NEW ENTRANTS 100 5.9.2 THREAT OF SUBSTITUTES 100 5.9.3 BARGAINING POWER OF SUPPLIERS 100 5.9.4 BARGAINING POWER OF BUYERS 100 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 101 5.10 TARIFF & REGULATORY LANDSCAPE 101 5.10.1 TARIFF DATA (HS CODE 9027) 101 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 5.10.3 REGULATORY FRAMEWORK 105 5.11 PRICING ANALYSIS 108 5.11.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS 108 5.11.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION 108 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 109 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 110 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 110 5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 110 5.13.3 BUYING CRITERIA 111 5.14 INVESTMENT AND FUNDING SCENARIO 112 5.15 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET 113 5.15.1 AI USE-CASES 114 5.15.2 KEY COMPANIES IMPLEMENTING AI 115 5.16 CASE STUDY ANALYSIS 115 5.16.1 COMPREHENSIVE SINGLE‑CELL TRANSCRIPTOMIC ATLAS OF HUMAN CORNEA 115 5.16.2 MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING IDENTIFIES RARE DRUG-RESISTANT CANCER SUBPOPULATIONS 115 5.16.3 SINGLE-CELL ANALYSIS OF RENAL CELL CARCINOMA REVEALS TUMOR HETEROGENEITY AND MICROENVIRONMENTAL COMPLEXITY 116 5.17 US 2025 TARIFF IMPACT OVERVIEW 116 5.17.1 INTRODUCTION 116 5.17.2 KEY TARIFF RATES 117 5.17.3 PRICE IMPACT ANALYSIS 118 5.17.4 KEY IMPACT ON VARIOUS REGIONS 119 5.17.4.1 US 119 5.17.4.2 Europe 119 5.17.4.3 Asia Pacific 119 5.17.4.4 Rest of the World 120 5.17.5 END-USE INDUSTRY IMPACT 120 5.17.5.1 Pharmaceutical and biotech companies 120 5.17.5.2 Contract research organizations (CROs) 120 5.17.5.3 Academic & research institutes 121 6 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION 122 6.1 INTRODUCTION 123 6.2 RESEARCH APPLICATIONS 123 6.2.1 CANCER RESEARCH 127 6.2.1.1 Rising prevalence of cancer to drive market 127 6.2.2 IMMUNOLOGY RESEARCH 130 6.2.2.1 High incidence of immunological disorders to propel market 130 6.2.3 NEUROLOGY RESEARCH 133 6.2.3.1 Increasing incidence of neurological disorders to boost market 133 6.2.4 STEM CELL RESEARCH 136 6.2.4.1 Rising investments in stem cell research to drive market 136 6.2.5 OTHER RESEARCH APPLICATIONS 139 6.3 MEDICAL APPLICATIONS 142 6.3.1 NON-INVASIVE PRENATAL DIAGNOSIS 145 6.3.1.1 Increasing prevalence of genetic diseases to drive demand 145 6.3.2 IN VITRO FERTILIZATION 149 6.3.2.1 Growing demand for IVF procedures to support market 149 6.3.3 CIRCULATING TUMOR CELL DETECTION 152 6.3.3.1 Rising prevalence of cancer to contribute to segment growth 152 7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE 155 7.1 INTRODUCTION 156 7.2 HUMAN CELLS 156 7.2.1 GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND 156 7.3 ANIMAL CELLS 159 7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET 159 7.4 MICROBIAL CELLS 162 7.4.1 RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET 162 8 SINGLE-CELL ANALYSIS MARKET, BY END USER 166 8.1 INTRODUCTION 167 8.2 ACADEMIC & RESEARCH LABORATORIES 167 8.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET 167 8.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 171 8.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET 171 8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 174 8.4.1 HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND 174 8.5 CELL BANKS & IVF CENTERS 178 8.5.1 RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET 178 9 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 182 9.1 INTRODUCTION 183 9.2 CONSUMABLES 183 9.2.1 BEADS 186 9.2.1.1 Increasing use in research and genetic exploration to drive market 186 9.2.2 MICROPLATES 189 9.2.2.1 Rising frequency of product launches to boost market 189 9.2.3 REAGENTS 192 9.2.3.1 Advancements in single-cell genomics to increase demand 192 9.2.4 ASSAY KITS 195 9.2.4.1 Immunoassays 198 9.2.4.1.1 Growth in geriatric population to fuel demand 198 9.2.4.2 Cell-based assays 200 9.2.4.2.1 Increasing use in pharma and biopharma companies to drive market 200 9.2.5 OTHER CONSUMABLES 203 9.3 INSTRUMENTS 206 9.3.1 FLOW CYTOMETERS 209 9.3.1.1 Technological advancements to drive demand 209 9.3.2 NGS SYSTEMS 213 9.3.2.1 Increased affordability to support segment growth 213 9.3.3 PCR INSTRUMENTS 216 9.3.3.1 Rising use for DNA and mRNA amplification to boost market 216 9.3.4 SPECTROPHOTOMETERS 218 9.3.4.1 Technological advancements to boost market 218 9.3.5 CELL COUNTERS 221 9.3.5.1 Rising demand for automated cell counters to fuel market 221 9.3.6 MICROSCOPES 224 9.3.6.1 Increasing use in cell-based research to drive market 224 9.3.7 HCS SYSTEMS 227 9.3.7.1 Growing need for multi-parametric cell analysis to drive adoption 227 9.3.8 MICROARRAYS 229 9.3.8.1 Increasing development of targeted therapies to support market 229 9.3.9 OTHER INSTRUMENTS 232   10 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE 236 10.1 INTRODUCTION 237 10.2 FLOW CYTOMETRY 237 10.2.1 INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET 237 10.3 NEXT-GENERATION SEQUENCING 241 10.3.1 WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET 241 10.4 POLYMERASE CHAIN REACTION 244 10.4.1 INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET 244 10.5 MICROSCOPY 247 10.5.1 FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET 247 10.6 MASS SPECTROMETRY 250 10.6.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET 250 10.7 OTHER TECHNIQUES 253 11 SINGLE-CELL ANALYSIS MARKET, BY REGION 257 11.1 INTRODUCTION 258 11.2 NORTH AMERICA 258 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 263 11.2.2 US 264 11.2.2.1 Increasing R&D investments and funding to drive market 264 11.2.3 CANADA 269 11.2.3.1 High prevalence of hemophilia to propel market 269 11.3 EUROPE 273 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 277 11.3.2 GERMANY 278 11.3.2.1 Growing awareness of advanced cell therapies to support market 278 11.3.3 UK 282 11.3.3.1 Growing adoption of single-cell analysis products to drive demand 282 11.3.4 FRANCE 286 11.3.4.1 Growing government funding for R&D to propel market 286 11.3.5 ITALY 290 11.3.5.1 Focus on cell biology research to drive market 290 11.3.6 SPAIN 294 11.3.6.1 Increasing number of biotechnology companies to drive demand 294 11.3.7 REST OF EUROPE 298 11.4 ASIA PACIFIC 303 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 308 11.4.2 CHINA 309 11.4.2.1 Increasing R&D expenditure to support market 309 11.4.3 JAPAN 313 11.4.3.1 Increasing geriatric population to fuel demand 313 11.4.4 INDIA 317 11.4.4.1 Growing focus on development of cell-based therapies to boost market 317 11.4.5 SOUTH KOREA 321 11.4.5.1 Increasing number of strategic alliances to boost market 321 11.4.6 AUSTRALIA 325 11.4.6.1 Rising number of life science companies to boost demand 325 11.4.7 REST OF ASIA PACIFIC 329 11.5 LATIN AMERICA 333 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 337 11.5.2 BRAZIL 338 11.5.2.1 Rising focus on biotechnology industry to bolster market 338 11.5.3 MEXICO 342 11.5.3.1 Government support for biopharmaceutical production to drive market 342 11.5.4 REST OF LATIN AMERICA 346 11.6 MIDDLE EAST 350 11.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST 354 11.6.2 GCC 355 11.6.2.1 Saudi Arabia 359 11.6.2.1.1 Increasing healthcare expenditure to drive market 359 11.6.2.2 United Arab Emirates 363 11.6.2.2.1 Advancements in biopharmaceutical sector to drive demand 363 11.6.2.3 Rest of GCC 367 11.6.3 REST OF MIDDLE EAST 371 11.7 AFRICA 375 11.7.1 GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET 375 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 379 12 COMPETITIVE LANDSCAPE 381 12.1 OVERVIEW 381 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 381 12.3 REVENUE ANALYSIS, 2022–2024 386 12.4 MARKET SHARE ANALYSIS, 2024 387 12.4.1 RANKING OF KEY MARKET PLAYERS 389 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 389 12.5.1 STARS 389 12.5.2 EMERGING LEADERS 389 12.5.3 PERVASIVE PLAYERS 390 12.5.4 PARTICIPANTS 390 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 391 12.5.5.1 Company footprint 391 12.5.5.2 Product footprint 392 12.5.5.3 Region footprint 393 12.5.5.4 Technique footprint 394 12.5.5.5 Application footprint 395 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 396 12.6.1 PROGRESSIVE COMPANIES 396 12.6.2 RESPONSIVE COMPANIES 396 12.6.3 DYNAMIC COMPANIES 396 12.6.4 STARTING BLOCKS 396 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 398 12.6.5.1 Detailed list of key startups/SMEs 398 12.6.5.2 Competitive benchmarking of key startups/SMEs 399 12.7 COMPANY VALUATION AND FINANCIAL METRICS 400 12.8 BRAND/PRODUCT COMPARISON 401 12.9 COMPETITIVE SCENARIO 403 12.9.1 PRODUCT LAUNCHES 403 12.9.2 DEALS 405 12.9.3 EXPANSIONS 407 13 COMPANY PROFILES 408 13.1 INTRODUCTION 408 13.2 KEY PLAYERS 408 13.2.1 BD 408 13.2.1.1 Business overview 408 13.2.1.2 Products offered 409 13.2.1.3 Recent developments 411 13.2.1.3.1 Product launches 411 13.2.1.3.2 Deals 412 13.2.1.4 MnM view 412 13.2.1.4.1 Key strengths 412 13.2.1.4.2 Strategic choices 413 13.2.1.4.3 Weaknesses and competitive threats 413 13.2.2 THERMO FISHER SCIENTIFIC INC. 414 13.2.2.1 Business overview 414 13.2.2.2 Products offered 415 13.2.2.3 Recent developments 418 13.2.2.3.1 Product launches 418 13.2.2.3.2 Deals 418 13.2.2.4 MnM view 419 13.2.2.4.1 Key strengths 419 13.2.2.4.2 Strategic choices 419 13.2.2.4.3 Weaknesses and competitive threats 419 13.2.3 DANAHER CORPORATION 420 13.2.3.1 Business overview 420 13.2.3.2 Products offered 421 13.2.3.3 Recent developments 423 13.2.3.3.1 Deals 423 13.2.3.4 MnM view 424 13.2.3.4.1 Key strengths 424 13.2.3.4.2 Strategic choices 424 13.2.3.4.3 Weaknesses and competitive threats 424 13.2.4 10X GENOMICS 425 13.2.4.1 Business overview 425 13.2.4.2 Products offered 427 13.2.4.3 Recent developments 428 13.2.4.3.1 Product launches 428 13.2.4.3.2 Deals 429 13.2.5 MERCK KGAA 431 13.2.5.1 Business overview 431 13.2.5.2 Products offered 432 13.2.5.3 Recent developments 434 13.2.5.3.1 Deals 434 13.2.6 AGILENT TECHNOLOGIES, INC. 435 13.2.6.1 Business overview 435 13.2.6.2 Products offered 436 13.2.6.3 Recent developments 438 13.2.6.3.1 Product launches 438 13.2.6.3.2 Deals 439 13.2.7 QIAGEN 440 13.2.7.1 Business overview 440 13.2.7.2 Products offered 442 13.2.7.3 Recent developments 443 13.2.7.3.1 Deals 443 13.2.8 ILLUMINA, INC. 444 13.2.8.1 Business overview 444 13.2.8.2 Products offered 445 13.2.8.3 Recent developments 447 13.2.8.3.1 Product launches 447 13.2.8.3.2 Deals 447 13.2.9 BIO-RAD LABORATORIES, INC. 449 13.2.9.1 Business overview 449 13.2.9.2 Products offered 451 13.2.9.3 Recent developments 453 13.2.9.3.1 Product launches 453 13.2.10 DIASORIN S.P.A. 454 13.2.10.1 Business overview 454 13.2.10.2 Products offered 456 13.2.10.3 Recent developments 456 13.2.10.3.1 Deals 456 13.2.11 STANDARD BIOTOOLS 457 13.2.11.1 Business overview 457 13.2.11.2 Product offered 458 13.2.11.3 Recent developments 459 13.2.11.3.1 Product launches 459 13.2.11.3.2 Deals 460 13.2.12 TECAN TRADING AG 461 13.2.12.1 Business overview 461 13.2.12.2 Products offered 462 13.2.12.3 Recent developments 463 13.2.12.3.1 Product launches 463 13.2.12.3.2 Deals 463 13.2.13 SARTORIUS AG 464 13.2.13.1 Business overview 464 13.2.13.2 Products offered 465 13.2.13.3 Recent developments 466 13.2.13.3.1 Deals 466 13.2.13.3.2 Expansions 466 13.2.14 CORNING INCORPORATED 467 13.2.14.1 Business overview 467 13.2.14.2 Products offered 468 13.2.15 CYTEK BIOSCIENCES 469 13.2.15.1 Business overview 469 13.2.15.2 Products offered 470 13.2.15.3 Recent developments 470 13.2.15.3.1 Product launches 470 13.2.15.3.2 Deals 471 13.2.15.3.3 Expansions 471 13.2.16 TAKARA BIO INC. 472 13.2.16.1 Business overview 472 13.2.16.2 Products offered 473 13.2.16.3 Recent developments 475 13.2.16.3.1 Product launches 475 13.2.16.3.2 Deals 475   13.2.17 BIOMÉRIEUX 476 13.2.17.1 Business overview 476 13.2.17.2 Products offered 477 13.2.17.3 Recent developments 478 13.2.17.3.1 Deals 478 13.2.18 REVVITY 479 13.2.18.1 Business overview 479 13.2.18.2 Products offered 480 13.2.18.3 Recent developments 482 13.2.18.3.1 Deals 482 13.2.19 BIO-TECHNE 483 13.2.19.1 Business overview 483 13.2.19.2 Products offered 484 13.2.19.3 Recent developments 485 13.2.19.3.1 Deals 485 13.2.20 PACBIO 486 13.2.20.1 Business overview 486 13.2.20.2 Products offered 487 13.2.20.3 Recent developments 487 13.2.20.3.1 Product launches 487 13.2.21 BRUKER 488 13.2.21.1 Business overview 488 13.2.21.2 Products offered 490 13.2.21.3 Recent developments 491 13.2.21.3.1 Product launches 491 13.2.21.3.2 Deals 492 13.2.22 PROMEGA CORPORATION 493 13.2.22.1 Business overview 493 13.2.22.2 Products offered 493 13.2.23 OXFORD NANOPORE TECHNOLOGIES PLC 495 13.2.23.1 Business overview 495 13.2.23.2 Products offered 496 13.2.23.3 Recent developments 497 13.2.23.3.1 Deals 497 13.3 OTHER PLAYERS 498 13.3.1 SINGLERON BIOTECHNOLOGIES 498 13.3.2 CELL MICROSYSTEMS 499 13.3.3 NANOCELLECT BIOMEDICAL 500 13.3.4 RARECYTE, INC. 501 13.3.5 BICO 502 13.3.6 MENARINI GROUP 503 13.3.7 APOGEE FLOW SYSTEMS LTD 504 13.3.8 CREATIVE BIOLABS 505 13.3.9 SPHERE BIO 506 13.3.10 YOKOGAWA ELECTRIC CORPORATION 507 14 APPENDIX 508 14.1 DISCUSSION GUIDE 508 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 514 14.3 CUSTOMIZATION OPTIONS 516 14.4 RELATED REPORTS 516 14.5 AUTHOR DETAILS 517

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 60 TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS 72 TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES 73 TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035 74 TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION) 76 TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019–2025 77 TABLE 7 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS 85 TABLE 8 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS 86 TABLE 9 SINGLE-CELL ANALYSIS MARKET: END USERS 87 TABLE 10 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES 87 TABLE 11 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS 89 TABLE 12 TYPES OF BIOINFORMATICS TOOLS 91 TABLE 13 PATENTS FILED, 2014–2024 92 TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 94 TABLE 15 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND) 95 TABLE 16 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS) 96 TABLE 17 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND) 97 TABLE 18 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS) 98 TABLE 19 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 100 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103 TABLE 23 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104 TABLE 24 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES 105 TABLE 25 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022–2024 108 TABLE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 108 TABLE 27 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 109 TABLE 28 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER 111 TABLE 29 US ADJUSTED RECIPROCAL TARIFF RATES 117 TABLE 30 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS AND ELECTRICAL MACHINERY AND EQUIPMENT AND PARTS THEREOF 118 TABLE 31 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES 118 TABLE 32 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 123 TABLE 33 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 124 TABLE 34 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 35 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 36 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 37 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 38 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 39 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 40 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 41 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 42 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 43 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 44 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 45 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 46 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 47 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 48 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 49 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 50 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 51 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 52 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 53 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 54 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 56 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 57 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 58 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 59 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 60 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 61 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 63 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 64 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 65 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 66 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 67 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 68 GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 70 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 71 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 72 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 73 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 74 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 75 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 78 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 79 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 80 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 81 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 82 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 83 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 85 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 86 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 87 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 88 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 89 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 90 GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 92 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 93 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 94 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 95 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 96 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 97 GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 99 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 100 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 101 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 102 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 103 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 104 GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 156 TABLE 106 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 108 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 109 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 110 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 111 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 112 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 113 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 115 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 116 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 117 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 118 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 119 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 120 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 121 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 122 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 123 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 124 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 125 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 126 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 127 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 128 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 129 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 130 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 131 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 132 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 133 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 134 GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 135 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 136 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 138 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 139 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 140 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 141 GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 142 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 143 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 145 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 146 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 147 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 148 GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 149 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 150 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 151 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 152 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 153 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 154 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 155 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 156 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 157 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 158 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 159 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 160 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 161 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 162 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 163 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 164 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 165 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 166 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 167 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 168 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 169 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 170 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 171 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 172 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION, 2023–2030 (USD MILLION) 190 TABLE 173 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 174 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 175 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 176 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 177 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 178 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 179 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 180 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 181 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 182 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 183 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 184 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 185 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 186 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 187 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 188 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 189 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 190 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 191 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 192 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 193 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 194 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 195 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 196 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 197 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 198 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 199 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 200 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 201 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 202 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 203 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 204 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 205 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 206 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 207 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 208 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 203 TABLE 209 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 210 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 212 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 213 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 214 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 215 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 216 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 217 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 218 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 219 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 220 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 221 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 222 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 223 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 224 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 225 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 226 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 227 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 228 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 229 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 230 SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 213 TABLE 231 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 232 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 233 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 234 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 235 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 236 GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 237 SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 216 TABLE 238 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 239 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 240 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 241 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 242 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 243 GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 244 SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2023–2030 (USD MILLION) 219 TABLE 245 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 246 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 247 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 248 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 249 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 250 GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 251 SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION, 2023–2030 (USD MILLION) 222 TABLE 252 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 253 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 254 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 255 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 256 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 257 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 258 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION) 224 TABLE 259 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 260 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 261 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 263 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 264 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 265 SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 227 TABLE 266 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 267 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 268 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 269 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 270 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 271 GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 272 SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 273 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 274 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 275 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 276 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 277 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 278 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 279 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 233 TABLE 280 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 281 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 282 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 283 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 284 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 285 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 286 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 237 TABLE 287 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION) 238 TABLE 288 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 289 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 290 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 291 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 292 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 293 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 294 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2023–2030 (USD MILLION) 241 TABLE 295 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 296 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 297 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 298 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 299 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 300 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 301 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION) 245 TABLE 302 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 303 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 304 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 305 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 306 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 307 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 308 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2023–2030 (USD MILLION) 247 TABLE 309 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 310 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 311 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 312 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 313 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 314 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 315 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023–2030 (USD MILLION) 250 TABLE 316 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 317 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 318 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 319 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 320 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 321 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 322 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2023–2030 (USD MILLION) 254 TABLE 323 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 324 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 325 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 326 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 327 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 328 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 329 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2023–2030 (USD MILLION) 258 TABLE 330 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 331 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 260 TABLE 332 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 333 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 334 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 335 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 261 TABLE 336 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 262 TABLE 337 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 262 TABLE 338 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 339 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 340 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 263 TABLE 341 NORTH AMERICA: MACROECONOMIC INDICATORS 264 TABLE 342 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 265 TABLE 343 US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 344 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 345 US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 346 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 267 TABLE 347 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 268 TABLE 348 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 268 TABLE 349 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 350 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 351 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 269 TABLE 352 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 270 TABLE 353 CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 354 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 355 CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 356 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 271 TABLE 357 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 272 TABLE 358 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 272 TABLE 359 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 360 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 361 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 362 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 274 TABLE 363 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274 TABLE 364 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 365 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 366 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 367 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 275 TABLE 368 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 276 TABLE 369 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 370 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 371 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 372 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 373 EUROPE: MACROECONOMIC INDICATORS 278 TABLE 374 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 279 TABLE 375 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 376 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 377 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 378 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 280 TABLE 379 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 281 TABLE 380 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 281 TABLE 381 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 382 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 383 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 282 TABLE 384 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 283 TABLE 385 UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 386 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 387 UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 388 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 284 TABLE 389 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 285 TABLE 390 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 285 TABLE 391 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 392 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 393 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 286 TABLE 394 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 287 TABLE 395 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 396 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 397 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 398 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 288 TABLE 399 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 289 TABLE 400 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 289 TABLE 401 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 402 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 403 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 404 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 291 TABLE 405 ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 406 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 407 ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 408 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 292 TABLE 409 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 293 TABLE 410 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 293 TABLE 411 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 412 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 413 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 294 TABLE 414 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 295 TABLE 415 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 416 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 417 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 418 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 296 TABLE 419 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 297 TABLE 420 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 297 TABLE 421 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 422 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 423 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 298 TABLE 424 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 299 TABLE 425 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 426 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 427 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 428 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 300 TABLE 429 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 301 TABLE 430 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 301 TABLE 431 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 432 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 433 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 302 TABLE 434 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 305 TABLE 435 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 305 TABLE 436 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 437 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 438 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 439 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 306 TABLE 440 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 307 TABLE 441 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 307 TABLE 442 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 443 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 444 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 308 TABLE 445 ASIA PACIFIC: MACROECONOMIC INDICATORS 309 TABLE 446 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 310 TABLE 447 CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 448 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 449 CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 450 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 311 TABLE 451 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 312 TABLE 452 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 312 TABLE 453 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 454 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 455 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 313 TABLE 456 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 314 TABLE 457 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 458 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 459 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 460 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 315 TABLE 461 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 316 TABLE 462 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 316 TABLE 463 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 464 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 465 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 317 TABLE 466 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 318 TABLE 467 INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 468 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 469 INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 470 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 319 TABLE 471 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 320 TABLE 472 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 320 TABLE 473 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 474 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 475 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 476 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 322 TABLE 477 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 478 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 479 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 480 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 323 TABLE 481 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 324 TABLE 482 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 324 TABLE 483 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 484 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 485 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 325 TABLE 486 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 326 TABLE 487 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 488 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 489 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 490 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 327 TABLE 491 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 328 TABLE 492 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 328 TABLE 493 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 494 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 495 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 329 TABLE 496 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 330 TABLE 497 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 498 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 499 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 500 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 331 TABLE 501 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 332 TABLE 502 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 332 TABLE 503 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 504 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 505 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 333 TABLE 506 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 334 TABLE 507 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 334 TABLE 508 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 509 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 510 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 511 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 335 TABLE 512 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 336 TABLE 513 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 336 TABLE 514 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 515 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 516 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 337 TABLE 517 LATIN AMERICA: MACROECONOMIC INDICATORS 338 TABLE 518 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 338 TABLE 519 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 520 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 521 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 522 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 340 TABLE 523 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 341 TABLE 524 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 341 TABLE 525 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 526 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 527 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 342 TABLE 528 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 343 TABLE 529 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 530 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 531 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 532 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 344 TABLE 533 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 345 TABLE 534 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 345 TABLE 535 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 536 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 537 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 346 TABLE 538 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 347 TABLE 539 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 540 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 541 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 542 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 348 TABLE 543 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 349 TABLE 544 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 349 TABLE 545 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 546 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 547 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 350 TABLE 548 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 351 TABLE 549 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 351 TABLE 550 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 551 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 552 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 553 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 352 TABLE 554 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 353 TABLE 555 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 353 TABLE 556 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 557 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 558 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 354 TABLE 559 MIDDLE EAST: MACROECONOMIC INDICATORS 355 TABLE 560 GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 355 TABLE 561 GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 356 TABLE 562 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 563 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 564 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 565 GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 357 TABLE 566 GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 358 TABLE 567 GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 358 TABLE 568 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 569 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 570 GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 359 TABLE 571 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 360 TABLE 572 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 573 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 574 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 575 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 361 TABLE 576 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 362 TABLE 577 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 362 TABLE 578 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 579 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 580 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 363 TABLE 581 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 364 TABLE 582 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 583 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 584 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 585 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 365 TABLE 586 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 366 TABLE 587 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 366 TABLE 588 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 589 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 590 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 367 TABLE 591 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 368 TABLE 592 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 593 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 594 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 595 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 369 TABLE 596 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 370 TABLE 597 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 370 TABLE 598 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 599 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 600 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 371 TABLE 601 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 372 TABLE 602 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 603 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 604 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 605 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 373 TABLE 606 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 374 TABLE 607 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 374 TABLE 608 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 609 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 610 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 375 TABLE 611 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 376 TABLE 612 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 613 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 614 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 615 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION) 377 TABLE 616 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 378 TABLE 617 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 378 TABLE 618 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 619 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 379 TABLE 620 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION) 379 TABLE 621 MACROECONOMIC OUTLOOK FOR AFRICA 380 TABLE 622 SINGLE-CELL ANALYSIS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025 381 TABLE 623 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION 388 TABLE 624 SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT 392 TABLE 625 SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT 393 TABLE 626 SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT 394 TABLE 627 SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT 395 TABLE 628 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 398 TABLE 629 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 399 TABLE 630 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 403 TABLE 631 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021–APRIL 2025 405 TABLE 632 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025 407 TABLE 633 BD: COMPANY OVERVIEW 408 TABLE 634 BD: PRODUCTS OFFERED 409 TABLE 635 BD: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 411 TABLE 636 BD: DEALS, JANUARY 2021–APRIL 2025 412 TABLE 637 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 414 TABLE 638 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 415 TABLE 639 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 418 TABLE 640 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–APRIL 2025 418 TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW 420 TABLE 642 DANAHER CORPORATION: PRODUCTS OFFERED 421 TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2021–APRIL 2025 423 TABLE 644 10X GENOMICS: COMPANY OVERVIEW 425 TABLE 645 10X GENOMICS: PRODUCTS OFFERED 427 TABLE 646 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 428 TABLE 647 10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025 429 TABLE 648 MERCK KGAA: COMPANY OVERVIEW 431 TABLE 649 MERCK KGAA: PRODUCTS OFFERED 432 TABLE 650 MERCK KGAA: DEALS, JANUARY 2021–APRIL 2025 434 TABLE 651 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 435 TABLE 652 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 436 TABLE 653 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 438 TABLE 654 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–APRIL 2025 439 TABLE 655 QIAGEN: COMPANY OVERVIEW 440 TABLE 656 QIAGEN: PRODUCTS OFFERED 442 TABLE 657 QIAGEN: DEALS, JANUARY 2021–APRIL 2025 443 TABLE 658 ILLUMINA, INC.: COMPANY OVERVIEW 444 TABLE 659 ILLUMINA, INC.: PRODUCTS OFFERED 445 TABLE 660 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 447 TABLE 661 ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025 447 TABLE 662 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 449 TABLE 663 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 451 TABLE 664 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 453 TABLE 665 DIASORIN S.P.A.: COMPANY OVERVIEW 454 TABLE 666 DIASORIN S.P.A.: PRODUCTS OFFERED 456 TABLE 667 DIASORIN S.P.A.: DEALS, JANUARY 2021–APRIL 2025 456 TABLE 668 STANDARD BIOTOOLS: COMPANY OVERVIEW 457 TABLE 669 STANDARD BIOTOOLS: PRODUCTS OFFERED 458 TABLE 670 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 459 TABLE 671 STANDARD BIOTOOLS: DEALS, JANUARY 2021–APRIL 2025 460 TABLE 672 TECAN TRADING AG: COMPANY OVERVIEW 461 TABLE 673 TECAN TRADING AG: PRODUCTS OFFERED 462 TABLE 674 TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 463 TABLE 675 TECAN TRADING AG: DEALS, JANUARY 2021–APRIL 2025 463 TABLE 676 SARTORIUS AG: COMPANY OVERVIEW 464 TABLE 677 SARTORIUS AG: PRODUCTS OFFERED 465 TABLE 678 SARTORIUS AG: DEALS, JANUARY 2021–APRIL 2025 466 TABLE 679 SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2025 466 TABLE 680 CORNING INCORPORATED: COMPANY OVERVIEW 467 TABLE 681 CORNING INCORPORATED: PRODUCTS OFFERED 468 TABLE 682 CYTEK BIOSCIENCES: COMPANY OVERVIEW 469 TABLE 683 CYTEK BIOSCIENCES: PRODUCTS OFFERED 470 TABLE 684 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 470 TABLE 685 CYTEK BIOSCIENCES: DEALS, JANUARY 2021–APRIL 2025 471 TABLE 686 CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–APRIL 2025 471 TABLE 687 TAKARA BIO INC.: COMPANY OVERVIEW 472 TABLE 688 TAKARA BIO INC.: PRODUCTS OFFERED 473 TABLE 689 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 475 TABLE 690 TAKARA BIO INC.: DEALS, JANUARY 2021–APRIL 2025 475 TABLE 691 BIOMÉRIEUX: COMPANY OVERVIEW 476 TABLE 692 BIOMÉRIEUX: PRODUCTS OFFERED 477 TABLE 693 BIOMÉRIEUX: DEALS, JANUARY 2021–APRIL 2025 478 TABLE 694 REVVITY: COMPANY OVERVIEW 479 TABLE 695 REVVITY: PRODUCTS OFFERED 480 TABLE 696 REVVITY: DEALS, JANUARY 2021–APRIL 2025 482 TABLE 697 BIO-TECHNE: COMPANY OVERVIEW 483 TABLE 698 BIO-TECHNE: PRODUCTS OFFERED 484 TABLE 699 BIO-TECHNE: DEALS 485 TABLE 700 PACBIO: COMPANY OVERVIEW 486 TABLE 701 PACBIO: PRODUCTS OFFERED 487 TABLE 702 PACBIO: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 487 TABLE 703 BRUKER: COMPANY OVERVIEW 488 TABLE 704 BRUKER: PRODUCTS OFFERED 490 TABLE 705 BRUKER: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 491 TABLE 706 BRUKER: DEALS, JANUARY 2021–APRIL 2025 492 TABLE 707 PROMEGA CORPORATION: COMPANY OVERVIEW 493 TABLE 708 PROMEGA CORPORATION: PRODUCTS OFFERED 493 TABLE 709 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 495 TABLE 710 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED 496 TABLE 711 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021–APRIL 2025 497 TABLE 712 SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW 498 TABLE 713 CELL MICROSYSTEMS: COMPANY OVERVIEW 499 TABLE 714 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW 500 TABLE 715 RARECYTE, INC.: COMPANY OVERVIEW 501 TABLE 716 BICO: COMPANY OVERVIEW 502 TABLE 717 MENARINI GROUP: COMPANY OVERVIEW 503 TABLE 718 APOGEE FLOW SYSTEMS LTD: COMPANY OVERVIEW 504 TABLE 719 CREATIVE BIOLABS: COMPANY OVERVIEW 505 TABLE 720 SPHERE BIO: COMPANY OVERVIEW 506 TABLE 721 YOKOGAWA ELECTRIC CORPORATION: COMPANY OVERVIEW 507 FIGURE 1 SINGLE-CELL ANALYSIS MARKET: RESEARCH DESIGN 52 FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET 54 FIGURE 3 SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 55 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024 56 FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2024 56 FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 57 FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 58 FIGURE 8 SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS 59 FIGURE 9 DATA TRIANGULATION METHODOLOGY 61 FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 64 FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2025 VS. 2030 (USD MILLION) 65 FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION) 65 FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 66 FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 66 FIGURE 15 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET 67 FIGURE 16 GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET 68 FIGURE 17 HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2024 69 FIGURE 18 CONSUMABLES SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2025 69 FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 70 FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 70 FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71 FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN MEN AND WOMEN, 2022 74 FIGURE 23 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014–2028 75 FIGURE 24 SHARE OF PERSONALIZED MEDICINE IN FDA'S NEW DRUG APPROVALS, 2015–2023 79 FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83 FIGURE 26 SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS 84 FIGURE 27 SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS 85 FIGURE 28 PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014–DECEMBER 2024 93 FIGURE 29 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 99 FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS 110 FIGURE 31 KEY BUYING CRITERIA FOR END USERS 111 FIGURE 32 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2023–2030 (THOUSAND UNITS) 210 FIGURE 33 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 259 FIGURE 34 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025 265 FIGURE 35 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 304 FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2022–2024 386 FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 387 FIGURE 38 RANKING OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2024 389 FIGURE 39 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 390 FIGURE 40 SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT 391 FIGURE 41 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023 397 FIGURE 42 EV/EBITDA OF KEY VENDORS 400 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 400 FIGURE 44 SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 401 FIGURE 45 BD: COMPANY SNAPSHOT (2024) 409 FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 415 FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 421 FIGURE 48 10X GENOMICS: COMPANY SNAPSHOT (2024) 426 FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT (2024) 432 FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 436 FIGURE 51 QIAGEN: COMPANY SNAPSHOT (2024) 441 FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2024) 445 FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 450 FIGURE 54 DIASORIN S.P.A.: COMPANY SNAPSHOT (2024) 455 FIGURE 55 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2024) 458 FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 462 FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2024) 465 FIGURE 58 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 468 FIGURE 59 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024) 469 FIGURE 60 TAKARA BIO INC.: COMPANY SNAPSHOT (2023) 473 FIGURE 61 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 477 FIGURE 62 REVVITY: COMPANY SNAPSHOT (2024) 480 FIGURE 63 BIO-TECHNE: COMPANY SNAPSHOT (2023) 484 FIGURE 64 PACBIO: COMPANY SNAPSHOT (2024) 486 FIGURE 65 BRUKER: COMPANY SNAPSHOT (2024) 489 FIGURE 66 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024) 495